“…Adenosine derivatives and its analogs massively influence the intracellular levels of GTP, UTP, CTP, NAD, and NADP (Green and Chan, 1973;Snyder et al, 1978;Bernofsky, 1980;Rapaport, 1980Rapaport, , 1983Rapaport, ,1988Schweinsberg et al, 1981;Nord et al, 1989). The reduction of NADP and NAD can affect several metabolic pathways like glycolysis, glutaminolysis, and the oxidative pentose-phosphate pathway, all of which are essential for cell proliferation and tumor formation (Lopez-Alarcon et al, 1979;Chapman et al, 1981;McKeehan, 1982;Groelke and Amos, 1984;Eigenbrodt et al, 1985;Lanks et al, 1986;Matsuno, 1987;Brand et al, 1987). All three pathways have been employed as targets for chemotherapeutic agents.…”